Vivo Bio Tech Concludes 39th AGM and Approves Director Re-Appointments
Vivo Bio Tech Ltd 路 Change in Management 路 01 Oct 2026, 12:27 am
Vivo Bio Tech Concludes 39th AGM and Approves Director Re-Appointments Vivo Bio Tech Limited conducted its 39th AGM on 30th Sep'26 via video conferencing. Key resolutions transacted included the adoption of audited standalone and consolidated financial statements for the fiscal year ended 31st Mar'26. Shareholders considered the re-appointment of Mr. Kalyan Ram Mangipudi (retiring by rotation), alongside the re-appointment of Whole-time Directors Mr. Sri Kalyan Kompella (effective 3rd Nov'26 to 2nd Nov'31) and Dr. Sankaranarayanan Alangudi (effective 6th Jan'27 to 5th Jan'32), each for five-year terms. Final voting results will be disseminated on or before 3rd Oct'26.
Original exchange filing (PDF)
More announcements from Vivo Bio Tech Ltd
- Please find the enclosed 路 13 Nov 2026
- Please find enclosed 路 12 Nov 2026
- Please find enclosed the Unaudited Financials for the Qtr and Half year ended 30th September, 2026 路 12 Nov 2026
- Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve Vivo Bio Tech Ltd has informed .... 路 11 Nov 2026
- Please find enclosed 路 13 Oct 2026
- Please find Enclosed 路 10 Oct 2026
- Please find enclosed scrutinizer''s report for 39th AGM 路 01 Oct 2026
- Please find enclosed 39th AGM proceedings 路 01 Oct 2026
